Vioxx Research - Osteoarthritis, Side-effects, Trials, Stroke, Heart Attack

Vioxx Research Today is a free monthly online journal that collates and summarizes the latest research about Vioxx, including details on osteoarthritis, side-effects, trials, stroke, heart attack.


Vioxx Research Today

Home

View Latest Issue

Information About Vioxx

Books on Vioxx

Advertising in Research Today

View Other Research Today Publications



Volume 3 (2006), Issue 9 (September)

  1. Impact of biomarkers on disease survival and progression in patients treated with octreotide for advanced hepatocellular carcinoma.
    J Cancer Res Clin Oncol, 132(11): 699-708. [Abstract] [Full-text]
  2. Cardiovascular risk of selective cyclooxygenase-2 inhibitors and other non-aspirin non-steroidal anti-inflammatory medications.
    Pharmacoepidemiol Drug Saf, 15(9): 641-52. [Abstract] [Full-text]
  3. Synthesis and biological evaluation of 1,3-diphenylprop-2-en-1-ones possessing a methanesulfonamido or an azido pharmacophore as cyclooxygenase-1/-2 inhibitors.
    Bioorg Med Chem, 14(20): 7044-50. [Abstract] [Full-text]
  4. Can the blood pressure effects of COX-2 selective inhibitors be explained by changes in plasma aldosterone levels?
    J Hypertens, 24(10): 1979-1984. [Abstract] [Full-text]
  5. Surgically induced osteoarthritis in the rat results in the development of both osteoarthritis-like joint pain and secondary hyperalgesia.
    Osteoarthritis Cartilage, 14(10): 1041-8. [Abstract] [Full-text]
  6. The lipoxygenase-cyclooxygenase inhibitor licofelone prevents thromboxane A2-mediated cardiovascular derangement triggered by the inflammatory peptide fMLP in the rabbit.
    Eur J Pharmacol, 546(1): 95-101. [Abstract] [Full-text]
  7. Enhancement of antinociception by coadministration of nonsteroidal anti-inflammatory drugs and soluble epoxide hydrolase inhibitors.
    Proc Natl Acad Sci U S A, 103(37): 13646-51. [Abstract] [Full-text]
  8. Differential effect of celecoxib on tissue factor expression in human endothelial and vascular smooth muscle cells.
    Biochem Biophys Res Commun, 349(2): 597-603. [Abstract] [Full-text]
  9. Divergent effects of rofecoxib on endothelial function and inflammation in acute coronary syndromes.
    Int J Cardiol, 112(3): 359-66. [Abstract] [Full-text]
  10. Risk of hospitalization for angio-oedema among users of newer COX-2 selective inhibitors and other nonsteroidal anti-inflammatory drugs.
    Br J Clin Pharmacol, 62(4): 496-501. [Abstract] [Full-text]
  11. Ibuprofen as a pre-emptive analgesic is as effective as rofecoxib for mandibular third molar surgery.
    Odontology, 94(1): 59-63. [Abstract] [Full-text]
  12. Prostaglandin/cyclooxygenase pathway in ghrelin-induced gastroprotection against ischemia-reperfusion injury.
    J Pharmacol Exp Ther, 319(1): 477-87. [Abstract] [Full-text]
  13. Nonsteroidal antiinflammatory drugs and acute myocardial infarction in patients with no major risk factors.
    Pharmacotherapy, 26(10): 1379-87. [Abstract] [Full-text]
  14. Extent of renal effect of cyclo-oxygenase-2-selective inhibitors is pharmacokinetic dependent.
    Clin Exp Pharmacol Physiol, 33(10): 917-24. [Abstract] [Full-text]
  15. Possible mechanisms of drug-induced aspirin and clopidogrel resistance.
    J Thromb Thrombolysis, 22(2): 139-50. [Abstract] [Full-text]
Place a permanent text-link or advertisement here.

© 2004-2014 Vioxx Research Today. All Rights Reserved.



Vioxx Research Today Archive:

Volume 1 (2004)
  Issue 1 (November)
  Issue 2 (December)

Volume 2 (2005)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 3 (2006)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 4 (2007)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 5 (2008)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 6 (2009)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 7 (2010)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 8 (2011)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 9 (2012)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 10 (2013)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 11 (2014)
  Issue 1 (January)
  Issue 2 (February)



Vioxx Books

Arthritis Survival: The Holistic Medical Treatment Program for Osteoarthritis

Arthritis Survival: The Holistic Medical Treatment Program for Osteoarthritis